Problems of Chronic Obstructive Pulmonary Disease (COPD) Among Workers

Agus Dwi Susanto

Abstract


Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles or gases. Occupational exposure as a one of important risk factor that contribute for COPD on nonsmoker patients. Several studies at population consistent showed that COPD correlated with hazards exposure at work place. COPD among workers can decrease quality of life, increase of work impairment, work disability and hospitalitation also increase of abstinentia from work and decrease of work productivity. Prevention were major action to prevent incident and morbidity of COPD among workers. Prevention programs including primary, secondary and tertiary prevention.

Keywords


COPD; Workers; Quality of Life; Disability; Work Productivity; Prevention

References


Global initiative for chronic obstructive lung disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease (2020 Report). Global Initiative for Chronic Obstructive Lung Disease, Inc. 2020.

World Health Organization. Chronic obstructive pulmonary disease (COPD) [Internet]. 2017 [cited 2017 Dec 1]. Avaliable from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd).

Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med. 2000;343:269-80.

Celli B. Chronic obstructive pulmonary disease. From unjustified nihilism to evidence-based optimism. Proc Am Thorac Soc. 2006;3:58-65.

Sadhra S, Kurmi OP, Sadhra SS, Lam KBH, Ayres JG. Occupational COPD and job exposure matrices: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2017;12:725-73.

Nguyen VN, Yunus F, Nguyen TPA, Dao Bich V, Damayanti T, Wiyono WH, et.al. The prevalence and patient characteristics of chronic obstructive pulmonary disease in non-smokers in Vietnam and Indonesia: An observational survey. Respirology. 2015;20(4):602-11.

Fishwick D, Sen D, Barber C, Bradshaw L, Robinson E, Sumner J. Occupational chronic obstructive pulmonary disease: a standard of care. J Occup Med. 2015;65:270–82.

Leleu M, Lesage FX, Drame M, Lebargy F, Deschamps F. Occupational risk factors for COPD: a case-control study. PLoS One. 2016;11(8):719-21.

Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet. 1997;349:1498-504.

Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan RI. Riset Kesehatan Dasar (Riskesdas) 2007. Laporan Nasional 2007; 2008. p275-85.

Vestbo J, Lange P. Epidemiology. In:Calverley PMA, Macnee W, Pride NB, Rennard SI eds. Chronic obstructive pulmonary disease. 2nd ed. London: Arnold;2003.p.21-50.

ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J. 2004;23:923-46.

Regional COPD Working Group. COPD prevalence in 12 Asia-Pasific countries and regions:projections based on the COPD prevalence estimation model. Respirology. 2003;8:192-8.

Lim S, Lam DC, Muttalif AR, Yunus F, Wongtim S, Lan le TT, et.al. Impact of chronic obstructive pulmonary disease (COPD) in the Asia-Pacific region: the EPIC Asia population-based survey. Asia Pac Fam Med. 2015;14(1):4.

Boschetto P, Quintavalle S, Miotto D, Lo Cascio N, Zeni E, Mapp CE. Chronic obstructive pulmonary disease (COPD) and occupational exposures. J Occup Med Toxicol. 2006;1:11.

Kraïm-Leleu M, Lesage F-X, Drame M, Lebargy F, Deschamps F. Occupational risk factors for COPD: a case-control study. PLoS ONE. 2016;11(8):719-21.

Raaschou-Nielsen O, Nielsen ML, Gehl J. Traffic-related air pollution:exposure and health effects in Copenhagen street cleaners and cemetery workers. Arch Environ Health. 1995;50:207-13.

Susanto AD, Antono W, Yunus F. Prevalensi penyakit paru obstruktif kronik pada penyapu jalan di Jakarta. J Indon Med Assoc. 2020;70:100-9.

Hannerz H, Tuchsen F. Hospital admissions among male drivers in Denmark. Occup Environ Med. 2001;58:253-60.

Dewi NR. Perbandingan waktu reaksi kelompok penyakit paru obstruktif kronik dan bukan penyakit paru obstruktif kronik pada pengemudi taksi x di Jakarta (tesis). Jakarta: Universitas Indonesia; 2019.

Renard SI, Barnes PJ. Pathogenesis COPD. In:Barnes PJ, Drazen JM, Renard S, Thomson NC eds. Asthma and COPD. Basic mechanism and clinical management. London: Academic Press;2002.p.361-79.

ATS Statement. Standards for the diagnostic and care of the patient with chronic obstructive lung disease. Am J Respir Crit Care Med. 1995;152:S77-120.

Fishwick D, Sen D, Barber C, Bradshaw L, Robinson E, Sumner J, et.al. The COPD standard collaboration group occupational chronic obstructive pulmonary disease: a standard of care. J Occup Med. 2015;65:270–82.

Health and Safety Executive. COPD causes - occupations and substances [Internet]. 2020 [cited 2019 Nov 21]. Available from: http://www.hse.gov.uk/copd/causes.htm.

Bang KM. Chronic obstructive pulmonary disease in nonsmokers by occupation and exposure: a brief review.Curr Opin Pulm Med. 2015;21(2):149-54.

O'Donnell DE, Laveneziana P. Physiology and consequences of lung hyperinflation in COPD. Eur Respir Rev. 2006;15:61-7.

Barnett M. Chronic obstructive pulmonary disease: a phenomenological study of patients' experiences. J Clin Nurs. 2005;14(7):805-12.

Cleland JA, Lee AJ, Hall S. Associations of depression and anxiety with gender, age, health-related quality of life and symptoms in primary care COPD patients. Fam Pract. 2007;24(3):217-23.

Cooper CB. Airflow obstruction and exercise. Respir Med. 2009;103(3):325-34.

ZuWallack R. How are you doing? What are you doing? Differing perspectives in the assessment of individuals with COPD.COPD 2007;4(3):293-7.

Wu M, Zhao Q, Chen Y, Fu C, Xu B. The quality of life and its association with direct medical costs for COPD in Urban China. Health Qual Life Outcomes. 2015;13:57-63.

Fletcher MJ, Upton J, Taylor-Fishwick J, Buist SA, Jenkins C, Hutton J, et.al. COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population. BMC Public Health. 2011;11:612-25.

Solem CT, Sun SX, Sudharshan L, Macahilig C, Katyal M, Gao X. Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2013;8:641-52.

Stephenson JJ, Cai Q, Mocarski M, Tan H, Doshi JA, Sullivan Det.al. Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2015;10:577-86.

Milanowska J, Mackiewicz B, Węgorowski P, Milanowski J, Milanowski P, Makara-Studzińska M. The quality of life of farmers with chronic obstructive pulmonary disease (COPD). Ann Agric Environ Med. 2017;24: 283-7.

Wheaton AG, Cunningham TJ, Ford ES, Croft JB. Employment and activity limitations among adult with chronic obstructive pulmonary disease- United States, 2013. Morbidity and Mortality Weeks Report. 2015;64(111):289-95.

Sin D, Stafinski T, Ng Y, Bell N, Jacobs P. The impact of chronic obstructive pulmonary disease on work loss in the United States. Am J Respir Crit Care Med. 2002;165(5):704–7.

Kremer AM, Pal TM, van Keimpema AR. Employment and disability for work in patients with COPD: a cross-sectional study among Dutch patients. Int Arch Occup Environ Health. 2006;80(1):78–86.

Hernandez P, Balter M, Bourbeau J, Hodder R. Living with chronic obstructive pulmonary disease: a survey of patients' knowledge and attitudes. Respir Med. 2009;103(7):1004-12.

Wouters EF. Economic analysis of the Confronting COPD survey: an overview of results. Respir Med. 2003;97(Suppl C):S3-14.

Patel JG, Coutinho AD, Lunacsek O, Dalal A. COPD affects worker productivity and health care costs. Int J Chron Obstruct Pulmon Dis. 2018;13:2301-11.

Wacker ME, Jorres RA, Schulz H, Heinrich J, Karrash CH, Karch A, et.al. Direct and indirect cost of COPD and itscomorbidities: Result from the German COSYCONET study. Respir Med. 2016;111:39-46.

Wouters EF. Economic analysis of the Confronting COPD survey: an overview of results. Respir Med. 2003;97:Suppl C:S3-14.

Patel JG, Nagar SP, Dalal AA. Indirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United States. Int J Chron Obstruct Pulmon Dis. 2014;9:289-300.

Jansson SA, Backman H, Stenling A, et al. Health economic costs of COPD in Sweden by disease severity-has it changed during a ten years period? Respir Med. 2013;107:1931-8.

DiBonaventura M, Paulose-Ram R, Su J, et al. The impact of COPD on quality of life, productivity loss, and resource use among the elderly United States workforce. COPD. 2012;9(1):46–57.

Sena R, Ahmed S, Tan WC, Li PZ, Labonté L, Aaron SD. Work productivity loss in mild to moderate COPD: lessons learned from the CanCOLD study. Eur Respir J. 2017;50:1701154.

Boschetto P, Quintavalle S, Miotto D, Lo Cascio N, Zeni E, Mapp CE. Chronic obstructive pulmonary disease (COPD) and Occupational Exposures. J Occup Med Toxicol. 2006;1(11):1-6.

NHLBI/WHO workshop report. Global initiative for chronic obstructive lung disease (GOLD). Geneva: World Health Organization. 2001 [cited 2020 Sept 25]. Available from: https://www.who.int/respiratory/copd/GOLD_WR_06.pdf.

Sutherland ER, Cherniack RB. Management of chronic obstructive pulmonary diasease. N Engl J Med. 2004;350:2689-97.

British Thoracic Society. Chronic obstructive pulmonary disease: national clinical guedeline on management of chronic obstructive pulmonary disease in adult in primary and secondary care. Thorax. 2004; 59(Suppl):1-232.

Sutherland ER. Outpatient treatment of chronic obstructive pulmonary disease: Comparisons with asthma. J Allergy Clin Immunol. 2004;114:715-24.




DOI: https://doi.org/10.36497/jri.v41i1.148

Refbacks

  • There are currently no refbacks.




Copyright (c) 2021 Agus Dwi Susanto

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


INDEXING & PARTNER

SINTA Garuda Indonesian Scientific Journal Database (ISJD) Indonesia One Search (IOS) Crossref

ROAD-ISSN Dimensions Google Scholar 

 

Jurnal Respirologi Indonesia
pISSN: 0853-7704 - eISSN: 2620-3162
Address: Jalan Cipinang Bunder No. 19, Cipinang, Pulogadung, Jakarta Timur, DKI Jakarta 13240, Indonesia
Phone: +62-21-2247-4845
Email: editor@jurnalrespirologi.org


An official publication by
the Indonesian Society of Respirology (ISR)

Creative Commons License
Creative Commons Attribution-NonCommercial 4.0 International License

Statcounter